The Pharmaceutical and Medical Device industries rely on a fragmented and complex supply chain to get product in to market. Your organisation or your suppliers could be conducting a single step or multiple steps of manufacture, and as such must adhere to the principles of GMP that apply to your operation and the market in which your product is...
For over 30 years SeerPharma has aided Pharmaceutical and Medical Device companies on matters of Quality Assurance and GMP compliance.
The current COVID-19 pandemic is seeing day to day quality related business operations challenged by attempting to deal with multiple personnel across different departments remotely. The need for immediate and...
INFOGRAPHIC: A snapshot of how SeerPharma supported its clients in 2019 on matters of Quality Assurance and GMP compliance.
INFOGRAPHIC: A snapshot of how SeerPharma has supported its clients in 2017 on matters of QA and GMP compliance.
PIC/S Authorities are coming to Melbourne in April 2017 and MTPConnect - the medical technology, biotechnology and pharmaceutical (MTP) Industry Growth Centre - is going to connect the Australian sector with PIC/S event participants.
Self inspection, commonly referred to as an internal audit, is a fundamental part of implementing, maintaining and improving your Pharmaceutical Quality System. Written into the PIC/S Guide to GMP as chapter 9 due to its criticality, Pharmaceutical manufacturers must ensure their self inspection programme is effective.
INFOGRAPHIC: A snapshot of how SeerPharma has supported its clients in 2016 on matters of QA and GMP compliance.
Quality Risk Management (QRM) is a GMP compliance requirement for Pharmaceutical organisations. The ICH Q9 guideline on Quality Risk Management (Annex 20 of the PIC/S GMP Guide) is expected to be adopted by manufacturers to ensure compliance with clauses 1.12 and 1.13 of Part I of the PIC/S GMP Guide:
We're excited to announce the first list of confirmed speakers for our Symposium to be held in Singapore on 16 - 17 March 2017: A Global Perspective on Effective Management of Risk-based GMP for Health Products.
As part of our commitment to the local biotech sector, SeerPharma was proud to sponsor a BioMelbourne Network session on Corporate Culture and Risk earlier this year.
Copyright © SeerPharma
